×

Get risk-on into year end: Mainstay advisor

Stocks are set to roar higher through the end of the year, David Kudla of Mainstay Capital Management said Friday.

"People were looking for a 10 percent correction," he said. "What we got in October, that's all we're going to get, and now it's time to be invested..."

The S&P 500 and the Dow Jones Industrial Average saw some of their largest selloffs in October but have since recovered to hit new highs.

Read MoreTen stocks for the next 25 years

On CNBC's "Halftime Report," Kudla said it was time to "add the beta trades through the end of the year."

David Kudla, Mainstay Capital Management CEO & Chief Investment Strategist
Adam Jeffery | CNBC
David Kudla, Mainstay Capital Management CEO & Chief Investment Strategist

Kudla, who oversees $1.9 billion in assets as CEO and chief investment strategist at Mainstay Capital Management, has been named by Barron's as one of the Top 100 Independent Financial Advisors.

Citing a positive U.S. jobs report and other economic data, Kudla said the outlook was upbeat.

Read More Jobs report shows solid but plodding improvement

"I'm not going to say the stars are perfectly aligned but we just think we're in a good setup to go forward," he said.

Kudla said he liked financials via the SPDR Select Sector Financial Sector exchange-traded fund, expecting that they would do well through the end of 2015.

"For higher-beta trades, we like technology," he said. "And we also like small caps through here."

Read MoreRegis Philbin shares his top stock picks

Most attractive in tech were the Nasdaq 100 and the PowerShares QQQ Trust, Kudla said, adding that growth was the focus.

"When we look at relative P/E ratios over a 15-year average, value is actually overvalued now," he said. "Growth is undervalued compared to 15-year averages. So, the value is in growth right now."

Kudla was also positive on small-cap stocks.

"We had a six-month period where small-cap stocks did get their 10 percent correction—and more. And coming off this Oct. 15 low, we've seen the Russell 2000 rally more than 10 percent through yesterday," he said. "And we just think that there's an opportunity here with the strong dollar that small companies that drive more of their revenue here domestically an opportunity for small caps to outperform."

Biotech plays, Biogen Idec and the iShares NASDAQ Biotechnology Index, were also among his top picks.

"We've had what's typically, traditionally been a defensive industry just become more of a growth industry, because of what's happening—pharma, medical devices, those areas," Kudla added.

Read MorePeter Thiel sees no bubble in tech stocks

The energy sector, which has experience a drop in crude oil prices to four-year lows, wasn't in play for Kudla.

"It's not that I don't like energy," he said. "It's that I don't know where the floor is in the price of oil."

When energy stocks disconnect from the price of oil, Kudla added, that's "where the buying opportunity is."

"There will be a time when it will be a screaming buy," he said.